AbbVie
ABBV
#25
Rank
A$576.28 B
Marketcap
$325.77
Share price
1.27%
Change (1 day)
16.58%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2024 (TTM): A$5.26 Billion

According to AbbVie's latest financial reports the company's current earnings are A$56.33 Billion. a decrease over its 2023 earnings that were of A$9.91 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2024

Annual earnings

Year Earnings Change
2024 A$5.89 B-40.54%
2023 A$9.91 B-53.62%
2022 A$21.38 B3.76%
2021 A$20.61 B282.25%
2020 A$5.39 B-59.67%
2019 A$13.37 B62.13%
2018 A$8.24 B-32.74%
2017 A$12.26 B-1.99%
2016 A$12.51 B18.65%
2015 A$10.54 B180.5%
2014 A$3.75 B-55.57%
2013 A$8.46 B-6.86%
2012 A$9.08 B56.05%
2011 A$5.82 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$17.63 B 199.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$13.3 Billion-325.48%๐Ÿ‡บ๐Ÿ‡ธ USA
A$20.12 B 241.24%๐Ÿ‡บ๐Ÿ‡ธ USA
A$7.31 B 24.03%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.09 B-81.43%๐Ÿ‡บ๐Ÿ‡ธ USA
A$3.02 B-48.71%๐Ÿ‡บ๐Ÿ‡ธ USA
A$6.97 B 18.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$16.55 B 180.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$0.81 B-86.19%๐Ÿ‡บ๐Ÿ‡ธ USA